The parent KBM-7 line used in this study contains the BCR-ABL1 gene fusion and potentially inactivating mutations in TP53 and NOTCH1, but lacks the other common genetic aberrations found in myeloid malignancies [38]. Here, ABL1 is linked to myeloid neoplasm.